Extendicare (TSE:EXE – Free Report) had its price objective hoisted by TD Securities from C$10.50 to C$13.00 in a research note issued to investors on Monday morning,BayStreet.CA reports. TD Securities currently has a hold rating on the stock.
Several other research analysts have also recently weighed in on EXE. Royal Bank of Canada boosted their price objective on shares of Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a report on Thursday, November 28th. BMO Capital Markets raised their price target on Extendicare from C$11.00 to C$13.50 in a research note on Monday. Finally, Cormark upgraded Extendicare to a “moderate buy” rating in a research report on Wednesday, February 19th. Three equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of C$11.50.
Get Our Latest Stock Report on Extendicare
Extendicare Trading Up 1.6 %
Extendicare Dividend Announcement
The firm also recently disclosed a monthly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 17th will be given a dividend of $0.04 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.67%. The ex-dividend date is Friday, February 28th. Extendicare’s payout ratio is 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
- Five stocks we like better than Extendicare
- How to Short Nasdaq: An Easy-to-Follow Guide
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- How to trade using analyst ratings
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- 3 Stocks to Consider Buying in October
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.